Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Delayed CNS myelination, Low muscle tone (hypotonia), Motor delay, and Self-biting and others; and very common findings: Abnormality of the mitochondrion. 61 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 20 | Encephalopathy, Seizure, Brain shrinkage (cerebral atrophy) |
Muscles | 9 | Low muscle tone (hypotonia), Generalized hypotonia, Axial hypotonia |
Eyes | 7 | Strabismus, Oculomotor apraxia, Damage to the optic nerve (optic atrophy) |
Digestive system | 2 | Feeding difficulties, Gastrostomy tube feeding in infancy |
Lab test results | 2 | Increased circulating lactate concentration, Elevated circulating hexacosanoic acid concentration |
Pregnancy and birth | 2 | Decreased fetal movement, Neonatal respiratory distress |
Bones and joints | 2 | Sideways curvature of the spine (scoliosis), Skeletal muscle atrophy |
Growth and development | 1 | Failure to thrive |
Head and neck | 1 | Microcephaly |
Lungs and breathing | 1 | Neonatal respiratory distress |
DNM1L encodes dynamin 1 like (736 aa). Functions in mitochondrial and peroxisomal division. Highest expression in Brain Cerebellar Hemisphere (97.7 TPM) and Brain Cerebellum (77.6 TPM).
Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1 is associated with mutations in the DNM1L gene on chromosome 12.
DNM1L is classified as a druggable target (Enzyme category) with score 0.0.
Genetic testing for DNM1L is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1 has been reported in the published literature.
Phenotype severity distribution: 23 always present features, 1 very common feature, 11 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1.
5 publications have been identified in PubMed for encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1. Research spans Basic Science / Preclinical (60%), Diagnostic / Biomarker (20%), and Review / Meta-Analysis (20%).
Xu H (2026). [PMID: 42687971](https://pubmed.ncbi.nlm.nih.gov/42687971/). *Front Neurol*. [Diagnostic / Biomarker]
Magistrati M (2025). [PMID: 39859560](https://pubmed.ncbi.nlm.nih.gov/39859560/). *International journal of molecular sciences*. [Review / Meta-Analysis]
Yang L (2025). [PMID: 41296099](https://pubmed.ncbi.nlm.nih.gov/41296099/). *Molecular neurobiology*. [Basic Science / Preclinical]
Wang YX (2025). [PMID: 40540175](https://pubmed.ncbi.nlm.nih.gov/40540175/). *Molecular neurobiology*. [Basic Science / Preclinical]
Wang Y (2025). [PMID: 40125832](https://pubmed.ncbi.nlm.nih.gov/40125832/). *CNS neuroscience & therapeutics*. [Basic Science / Preclinical]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 5:34 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center